History of TrumpRx in Timeline

By Popular Timelines Editorial Team · Updated: July 17, 2026

TrumpRx refers to a pharmaceutical-focused initiative proposed during Donald Trump’s political campaigns aimed at reforming the United States healthcare system. The core objective of the policy is to lower the high cost of prescription drugs for American consumers. Key proposals include implementing international reference pricing to align U.S. drug costs with lower prices paid in other countries, increasing transparency in pricing, and streamlining the FDA approval process to encourage competition. Proponents argue that these measures would dismantle monopolistic practices by pharmaceutical companies and provide much-needed relief to patients, particularly seniors. Critics, however, express concerns regarding the potential impact on pharmaceutical innovation and the long-term feasibility of government price controls. Overall, TrumpRx serves as a central pillar of Trump's broader platform to reduce healthcare expenditures through regulatory intervention and market-based reforms.

September 2025: Proposal for Price-Reducing Platform

In September 2025, Bloomberg News revealed that Trump administration officials were evaluating the creation of a new website intended to pressure pharmaceutical companies to lower drug prices to align with international standards.

October 2025: Expansion of TrumpRx Partnerships and Drug Offerings

In October 2025, the Trump administration secured a significant deal with AstraZeneca to include medications such as Farxiga, Airsupra, and FluMist on the platform via AstraZeneca Direct. Furthermore, during October 2025, EMD Serono reached an agreement to list its gonadotropin preparation drugs, specifically Gonal-f, on the TrumpRx service.

January 2026: TrumpRx Website Launch Delay

In January 2026, the anticipated launch of the TrumpRx website failed to occur as originally scheduled. Following this delay, Health and Human Services Secretary Robert F. Kennedy Jr. stated during a January 29, 2026, cabinet meeting that the platform would become operational within ten days, though an exact launch date remained unconfirmed.

January 2026: Scheduled Launch of TrumpRx Website

The TrumpRx website, which was officially announced in September 2025, was scheduled to go live and become operational in January 2026.

February 5, 2026: Launch of TrumpRx Website

On February 5, 2026, the official website for TrumpRx was officially launched to the public.

February 2026: Market Comparison and Competitive Availability of Medications

As of February 2026, it was noted that over half of the medications offered on TrumpRx either currently had or were expected to soon have more affordable generic alternatives accessible via other direct-to-consumer platforms, such as GoodRx and Mark Cuban's Cost Plus Drugs. The White House defended the service by highlighting that TrumpRx specifically focuses on providing the lowest possible pricing for branded pharmaceutical products.

February 2026: YouGov Survey on TrumpRx Public Perception

In February 2026, a YouGov survey revealed that the branding of the government website as 'TrumpRx' significantly polarized public opinion. While general support for the platform was relatively high, the association with the name 'TrumpRx' caused approval ratings to drop from 57% to 41% overall, with a sharp decline in support among Democrats and Independents, while simultaneously increasing enthusiasm among Republican users.

February 2026: Launch of TrumpRx

In February 2026, the second Trump administration officially launched TrumpRx, a federal website designed to provide American citizens with access to prescription medications at the lowest available prices globally.

March 2026: The New York Times analysis of TrumpRx pricing

In March 2026, The New York Times conducted an analysis revealing that while TrumpRx succeeded in reducing some prescription drug prices for American consumers, the platform failed to consistently provide prices lower than those found in other wealthy nations. In several instances, the drugs listed on TrumpRx were priced twice as high as the same medications in comparable international markets.

May 18, 2026: TrumpRx Platform Expansion

On May 18, 2026, President Trump officially announced a significant expansion of the TrumpRx website. This initiative added over 600 generic medications to the platform through new strategic partnerships with Amazon Pharmacy, GoodRx, and Cost Plus Drugs to increase accessibility for patients.

June 5, 2026: Expansion of TrumpRx Drug Catalog

On June 5, 2026, Trump announced a significant expansion of the TrumpRx platform, which included the addition of 160 new pharmaceutical drugs to the service's available catalog.

June 2026: TrumpRx Website Expansion

By June 2026, the TrumpRx website underwent significant growth, expanding its inventory to offer a selection of over 800 different medications to its users.